Education, Science, Technology, Innovation and Life
Open Access
Sign In

Insulin Resistance in Patients with Metabolic Syndrome

Download as PDF

DOI: 10.23977/medsc.2022.030518 | Downloads: 8 | Views: 470

Author(s)

Ping Jiang 1, Xuanguo Zhang 2, Binyu He 1

Affiliation(s)

1 Shaanxi University of Traditional Chinese Medicine, Xianyang ,China
2 Shaanxi Traditional Chinese Medicine Hospital, Xianyang ,China

Corresponding Author

Ping Jiang

ABSTRACT

MS (Metabolic Syndrome), which is a combination of obesity, hypertension, hyperglycemia and abnormal blood lipid levels, has increased the morbidity and mortality of cardiovascular and cerebrovascular diseases, and has become a chronic disease and public health problem seriously endangering human health. The occurrence of MS is closely related to various unhealthy lifestyles. If this is not intervened, the metabolic syndrome is bound to be a global epidemic, causing a huge burden to society. Insulin resistance mainly refers to the decrease of the sensitivity of the body to insulin regulating glucose metabolism, and will affect the metabolism of lipids, proteins, water and electrolytes. Therefore, this study intends to measure the insulin resistance index (HOMA-IR and a series of indicators) of a group of patients with metabolic syndrome and compare them with the normal control group. To investigate the relationship between serum leptin, IL-18, serum amyloid A and insulin resistance in patients with metabolic syndrome, so as to observe the improvement of insulin resistance.

KEYWORDS

Metabolic syndrome, Insulin resistance, HOMA-IR

CITE THIS PAPER

Ping Jiang, Xuanguo Zhang, Binyu He, Insulin Resistance in Patients with Metabolic Syndrome. MEDS Clinical Medicine (2022) Vol. 3: 101-105. DOI: http://dx.doi.org/10.23977/medsc.2022.030518.

REFERENCES

[1] Deen D. Abdominal Obesity (Metabolic Syndrome) – ScienceDirect [J]. Essential Family Medicine (Third Edition), 2016 (5): 397-401.
[2] Antonio, Vidal-Puig. Adipose tissue expandability, lipotoxicity and the metabolic syndrome [J]. Endocrinología Y Nutrición, 2018 (15): 69.
[3] Lin X H, Long-Gui L I. Peroxisome Proliferator Activated Receptor-γ (PPARγ) and Metabolic Syndrome [J]. Advances in Cardiovascular Diseases, 2017(6): 14.
[4] Moller D E, Kaufman K D. Metabolic Syndrome: A Clinical and Molecular Perspective - Annual Review of Medicine, 56 (1): 45 [J]. Annual Reviews, 2017 (4): 4.
[5] E Wirfält, Bo H, Bo G, et al. Food Patterns and Components of the Metabolic Syndrome in Men and Women: A Cross-sectional Study within the Malmö Diet and Cancer Cohort [J]. Am. J. Epidemiol, 2015 (4): 4.
[6] Chubb S, Hyde Z, Almeida O P, et al. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study [J]. European Journal of Endocrinology, 2018, 158(6): 785-792.
[7] Chen L, Jia W P, Jun-Xi L U. Prevalence of metabolic syndrome among Shanghai adults in China [J]. Chinese Journal of Cardiology, 2019 (34): 2.
[8] Xia J, Rong H Q. Inflammation and insulin resistance [J]. Medical Recapitulate, 2017, 582 (1): 1922.
[9] Vandanmagsar B, Youm Y H, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance [J]. Nature Medicine, 2021, 17(2): 179-188.
[10] Mdash I, NEJM. Insulin Resistance in Essential Hypertension — NEJM [J]. New England Journal of Medicine, 2020 (7): 2.
[11] Ueki K, Kondo T, Kahn C R. Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms [J]. Mol. Cell. Biol, 2019, 16(4): 3.

Downloads: 4536
Visits: 195378

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.